

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 4.14155753 |
| 2 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.68137649 |
| 3 | proteasome assembly (GO:0043248) | 3.50747950 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.45530765 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.39282587 |
| 6 | cellular response to zinc ion (GO:0071294) | 3.35954893 |
| 7 | immunoglobulin mediated immune response (GO:0016064) | 3.34690862 |
| 8 | protein maturation by protein folding (GO:0022417) | 3.31465667 |
| 9 | protein neddylation (GO:0045116) | 3.13935710 |
| 10 | platelet dense granule organization (GO:0060155) | 3.10130039 |
| 11 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.09319675 |
| 12 | ATP synthesis coupled proton transport (GO:0015986) | 3.09319675 |
| 13 | response to interferon-beta (GO:0035456) | 3.08973995 |
| 14 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.05027104 |
| 15 | respiratory electron transport chain (GO:0022904) | 3.02836318 |
| 16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.01090252 |
| 17 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.00665817 |
| 18 | electron transport chain (GO:0022900) | 2.97408203 |
| 19 | eosinophil chemotaxis (GO:0048245) | 2.97343205 |
| 20 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.97221892 |
| 21 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.94817315 |
| 22 | regulation of metalloenzyme activity (GO:0048552) | 2.90560595 |
| 23 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.82753621 |
| 24 | regulation of mononuclear cell migration (GO:0071675) | 2.76337009 |
| 25 | B cell mediated immunity (GO:0019724) | 2.76182300 |
| 26 | amino sugar catabolic process (GO:0046348) | 2.75468606 |
| 27 | membrane raft organization (GO:0031579) | 2.71149222 |
| 28 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.70598420 |
| 29 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.69794349 |
| 30 | granulocyte activation (GO:0036230) | 2.69652260 |
| 31 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.68041935 |
| 32 | eosinophil migration (GO:0072677) | 2.64288387 |
| 33 | oligosaccharide catabolic process (GO:0009313) | 2.63634237 |
| 34 | neutrophil activation (GO:0042119) | 2.63395440 |
| 35 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.60968351 |
| 36 | protein complex biogenesis (GO:0070271) | 2.59073439 |
| 37 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.56511335 |
| 38 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.54921217 |
| 39 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.54921217 |
| 40 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.53800738 |
| 41 | keratan sulfate catabolic process (GO:0042340) | 2.51846634 |
| 42 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.51248831 |
| 43 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.50129923 |
| 44 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.50129923 |
| 45 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.50129923 |
| 46 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.49973151 |
| 47 | cytochrome complex assembly (GO:0017004) | 2.48495024 |
| 48 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.46242111 |
| 49 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.45085128 |
| 50 | negative regulation of ligase activity (GO:0051352) | 2.45085128 |
| 51 | glycosphingolipid catabolic process (GO:0046479) | 2.43140166 |
| 52 | type I interferon signaling pathway (GO:0060337) | 2.43128044 |
| 53 | cellular response to type I interferon (GO:0071357) | 2.43128044 |
| 54 | negative regulation of interleukin-12 production (GO:0032695) | 2.42404697 |
| 55 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.39700309 |
| 56 | chaperone-mediated protein transport (GO:0072321) | 2.39370551 |
| 57 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.38795315 |
| 58 | cytidine deamination (GO:0009972) | 2.38696971 |
| 59 | cytidine metabolic process (GO:0046087) | 2.38696971 |
| 60 | cytidine catabolic process (GO:0006216) | 2.38696971 |
| 61 | xenobiotic catabolic process (GO:0042178) | 2.38522496 |
| 62 | response to peptidoglycan (GO:0032494) | 2.37215765 |
| 63 | DNA deamination (GO:0045006) | 2.36988866 |
| 64 | * phagosome maturation (GO:0090382) | 2.36906094 |
| 65 | response to type I interferon (GO:0034340) | 2.36822110 |
| 66 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.35277910 |
| 67 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.35277910 |
| 68 | autophagic vacuole fusion (GO:0000046) | 2.34636064 |
| 69 | lymphocyte chemotaxis (GO:0048247) | 2.30062380 |
| 70 | respiratory chain complex IV assembly (GO:0008535) | 2.29171978 |
| 71 | signal peptide processing (GO:0006465) | 2.28971591 |
| 72 | regulation of interleukin-8 secretion (GO:2000482) | 2.28554862 |
| 73 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.28189897 |
| 74 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.27946815 |
| 75 | regulation of monocyte chemotaxis (GO:0090025) | 2.27152596 |
| 76 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.27043893 |
| 77 | glycolipid catabolic process (GO:0019377) | 2.26887697 |
| 78 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.26644003 |
| 79 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.26578011 |
| 80 | lipoxygenase pathway (GO:0019372) | 2.26391974 |
| 81 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.26160396 |
| 82 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.26105838 |
| 83 | organelle membrane fusion (GO:0090174) | 2.20159245 |
| 84 | regulation of cellular amine metabolic process (GO:0033238) | 2.19723705 |
| 85 | regulation of T cell tolerance induction (GO:0002664) | 2.17940550 |
| 86 | * hydrogen ion transmembrane transport (GO:1902600) | 2.17682147 |
| 87 | response to interferon-gamma (GO:0034341) | 2.17645614 |
| 88 | cellular response to cadmium ion (GO:0071276) | 2.16042623 |
| 89 | regulation of oxidative phosphorylation (GO:0002082) | 2.15843392 |
| 90 | phagocytosis, engulfment (GO:0006911) | 2.14989874 |
| 91 | myeloid cell activation involved in immune response (GO:0002275) | 2.14788775 |
| 92 | regulation of T cell migration (GO:2000404) | 2.14760587 |
| 93 | regulation of antigen processing and presentation (GO:0002577) | 2.13790707 |
| 94 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.13122245 |
| 95 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.12666486 |
| 96 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.12134725 |
| 97 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.11813381 |
| 98 | glucosamine-containing compound catabolic process (GO:1901072) | 2.10723114 |
| 99 | macrophage chemotaxis (GO:0048246) | 2.10410909 |
| 100 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.10084115 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.21119580 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.54719311 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.12876035 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.07002862 |
| 5 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.89656070 |
| 6 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.84960071 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.81634019 |
| 8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.81557990 |
| 9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.64043444 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.57609019 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.47104911 |
| 12 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.39277812 |
| 13 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.36433561 |
| 14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.34323399 |
| 15 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.25078866 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.18879810 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.10679214 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.06859215 |
| 19 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.01522374 |
| 20 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.97257629 |
| 21 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97141952 |
| 22 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.96258452 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.94563864 |
| 24 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.90789330 |
| 25 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.89543432 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.86291227 |
| 27 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.86166503 |
| 28 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.85347753 |
| 29 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.79603852 |
| 30 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.77837863 |
| 31 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.76461343 |
| 32 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.74489602 |
| 33 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73703704 |
| 34 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.73081361 |
| 35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64761887 |
| 36 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.59018155 |
| 37 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.56502773 |
| 38 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.56211278 |
| 39 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.54179080 |
| 40 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.54153637 |
| 41 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.52088905 |
| 42 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.51637636 |
| 43 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.51528487 |
| 44 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.48781515 |
| 45 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.45281414 |
| 46 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.42151981 |
| 47 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.42104461 |
| 48 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.39983825 |
| 49 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.37903816 |
| 50 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.34478973 |
| 51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.33018559 |
| 52 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.30154358 |
| 53 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.29726319 |
| 54 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.29499748 |
| 55 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28456591 |
| 56 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.28089316 |
| 57 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.26433160 |
| 58 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26034209 |
| 59 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.25779088 |
| 60 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23647229 |
| 61 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23036744 |
| 62 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.21405779 |
| 63 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.20484094 |
| 64 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.20170020 |
| 65 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.20085870 |
| 66 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.17399318 |
| 67 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.16096028 |
| 68 | SPI1_23127762_ChIP-Seq_K562_Human | 1.15249843 |
| 69 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.14511501 |
| 70 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.14377823 |
| 71 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13919860 |
| 72 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.13532020 |
| 73 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12067059 |
| 74 | * MYB_26560356_Chip-Seq_TH2_Human | 1.11889353 |
| 75 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.09412955 |
| 76 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.08615885 |
| 77 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08269927 |
| 78 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08074915 |
| 79 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.07836433 |
| 80 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.07342133 |
| 81 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.06796185 |
| 82 | * STAT1_20625510_ChIP-Seq_HELA_Human | 1.05667676 |
| 83 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05480325 |
| 84 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.01516590 |
| 85 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01514163 |
| 86 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99345300 |
| 87 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.98586199 |
| 88 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.98116843 |
| 89 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.96863037 |
| 90 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.94542471 |
| 91 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92608320 |
| 92 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92595893 |
| 93 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92402332 |
| 94 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91733864 |
| 95 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90935980 |
| 96 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.90108337 |
| 97 | AR_20517297_ChIP-Seq_VCAP_Human | 0.89494816 |
| 98 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88720852 |
| 99 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.86999419 |
| 100 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.86642084 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 3.52692490 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.26564528 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.14933260 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 2.80360594 |
| 5 | MP0009785_altered_susceptibility_to | 2.77998217 |
| 6 | MP0003724_increased_susceptibility_to | 2.70758466 |
| 7 | MP0006082_CNS_inflammation | 2.68451335 |
| 8 | MP0005464_abnormal_platelet_physiology | 2.60756735 |
| 9 | MP0005671_abnormal_response_to | 2.56707956 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.53092482 |
| 11 | MP0000685_abnormal_immune_system | 2.27673432 |
| 12 | MP0009840_abnormal_foam_cell | 2.23765511 |
| 13 | MP0003436_decreased_susceptibility_to | 2.21285514 |
| 14 | MP0003186_abnormal_redox_activity | 2.18178587 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.15473628 |
| 16 | MP0000343_altered_response_to | 2.12128227 |
| 17 | MP0002419_abnormal_innate_immunity | 2.08165429 |
| 18 | MP0005387_immune_system_phenotype | 2.03075359 |
| 19 | MP0001790_abnormal_immune_system | 2.03075359 |
| 20 | MP0003172_abnormal_lysosome_physiology | 1.99800494 |
| 21 | MP0006054_spinal_hemorrhage | 1.99381292 |
| 22 | MP0005025_abnormal_response_to | 1.98025352 |
| 23 | MP0003950_abnormal_plasma_membrane | 1.85696090 |
| 24 | MP0002452_abnormal_antigen_presenting | 1.82288288 |
| 25 | MP0001853_heart_inflammation | 1.79268245 |
| 26 | MP0008438_abnormal_cutaneous_collagen | 1.77759744 |
| 27 | MP0003075_altered_response_to | 1.75334042 |
| 28 | MP0001533_abnormal_skeleton_physiology | 1.73682586 |
| 29 | MP0002723_abnormal_immune_serum | 1.73405538 |
| 30 | MP0003303_peritoneal_inflammation | 1.72832717 |
| 31 | MP0001845_abnormal_inflammatory_respons | 1.72155060 |
| 32 | MP0001800_abnormal_humoral_immune | 1.69934257 |
| 33 | MP0002139_abnormal_hepatobiliary_system | 1.69919003 |
| 34 | MP0009764_decreased_sensitivity_to | 1.65155967 |
| 35 | MP0001542_abnormal_bone_strength | 1.60452176 |
| 36 | MP0009333_abnormal_splenocyte_physiolog | 1.59881236 |
| 37 | MP0008469_abnormal_protein_level | 1.53959455 |
| 38 | MP0002420_abnormal_adaptive_immunity | 1.52061591 |
| 39 | MP0001819_abnormal_immune_cell | 1.52016499 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.44425756 |
| 41 | MP0003195_calcinosis | 1.44171833 |
| 42 | MP0010386_abnormal_urinary_bladder | 1.39547676 |
| 43 | MP0005165_increased_susceptibility_to | 1.38123775 |
| 44 | MP0003300_gastrointestinal_ulcer | 1.32960119 |
| 45 | MP0005408_hypopigmentation | 1.32087849 |
| 46 | MP0006036_abnormal_mitochondrial_physio | 1.31146195 |
| 47 | MP0008004_abnormal_stomach_pH | 1.30168386 |
| 48 | MP0000858_altered_metastatic_potential | 1.28593854 |
| 49 | MP0002405_respiratory_system_inflammati | 1.27858675 |
| 50 | MP0005365_abnormal_bile_salt | 1.22959726 |
| 51 | MP0003279_aneurysm | 1.18938765 |
| 52 | MP0002277_abnormal_respiratory_mucosa | 1.18120918 |
| 53 | MP0005075_abnormal_melanosome_morpholog | 1.17785353 |
| 54 | MP0005164_abnormal_response_to | 1.17734583 |
| 55 | MP0003011_delayed_dark_adaptation | 1.16720245 |
| 56 | MP0004510_myositis | 1.12340775 |
| 57 | MP0002138_abnormal_hepatobiliary_system | 1.11407859 |
| 58 | MP0003448_altered_tumor_morphology | 1.08517311 |
| 59 | MP0002254_reproductive_system_inflammat | 1.06982773 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.03928678 |
| 61 | MP0005166_decreased_susceptibility_to | 1.03521291 |
| 62 | MP0000716_abnormal_immune_system | 1.02484996 |
| 63 | MP0009763_increased_sensitivity_to | 1.02142943 |
| 64 | MP0002295_abnormal_pulmonary_circulatio | 1.01522704 |
| 65 | MP0002837_dystrophic_cardiac_calcinosis | 1.01428087 |
| 66 | MP0004947_skin_inflammation | 1.01172644 |
| 67 | MP0005084_abnormal_gallbladder_morpholo | 1.00349146 |
| 68 | MP0001756_abnormal_urination | 0.99910095 |
| 69 | MP0000604_amyloidosis | 0.99255991 |
| 70 | MP0008875_abnormal_xenobiotic_pharmacok | 0.98982996 |
| 71 | MP0000372_irregular_coat_pigmentation | 0.98144152 |
| 72 | MP0001958_emphysema | 0.97361612 |
| 73 | MP0002877_abnormal_melanocyte_morpholog | 0.96684029 |
| 74 | MP0005023_abnormal_wound_healing | 0.96520503 |
| 75 | MP0009643_abnormal_urine_homeostasis | 0.96413175 |
| 76 | MP0004019_abnormal_vitamin_homeostasis | 0.95679683 |
| 77 | MP0005319_abnormal_enzyme/_coenzyme | 0.95664267 |
| 78 | MP0000015_abnormal_ear_pigmentation | 0.94294059 |
| 79 | MP0003866_abnormal_defecation | 0.94108306 |
| 80 | MP0005360_urolithiasis | 0.93770273 |
| 81 | MP0004883_abnormal_blood_vessel | 0.93351094 |
| 82 | MP0002132_abnormal_respiratory_system | 0.90792167 |
| 83 | MP0005390_skeleton_phenotype | 0.89819443 |
| 84 | MP0005332_abnormal_amino_acid | 0.86070985 |
| 85 | MP0000689_abnormal_spleen_morphology | 0.85973035 |
| 86 | MP0002429_abnormal_blood_cell | 0.84957303 |
| 87 | MP0002398_abnormal_bone_marrow | 0.84454790 |
| 88 | MP0000465_gastrointestinal_hemorrhage | 0.83395666 |
| 89 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.82966330 |
| 90 | MP0005310_abnormal_salivary_gland | 0.82689371 |
| 91 | MP0003795_abnormal_bone_structure | 0.82203419 |
| 92 | MP0002693_abnormal_pancreas_physiology | 0.80677435 |
| 93 | MP0002166_altered_tumor_susceptibility | 0.80300744 |
| 94 | MP0009780_abnormal_chondrocyte_physiolo | 0.79844859 |
| 95 | MP0005174_abnormal_tail_pigmentation | 0.79168872 |
| 96 | MP0008260_abnormal_autophagy | 0.78388671 |
| 97 | MP0002876_abnormal_thyroid_physiology | 0.78270704 |
| 98 | MP0005085_abnormal_gallbladder_physiolo | 0.77873980 |
| 99 | MP0005379_endocrine/exocrine_gland_phen | 0.74362417 |
| 100 | MP0002136_abnormal_kidney_physiology | 0.74044396 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 4.97192546 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.97192546 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.97192546 |
| 4 | Vacuolated lymphocytes (HP:0001922) | 4.47426834 |
| 5 | Petechiae (HP:0000967) | 3.77761556 |
| 6 | Abnormality of macrophages (HP:0004311) | 3.73701000 |
| 7 | Acute necrotizing encephalopathy (HP:0006965) | 3.35539496 |
| 8 | Dysostosis multiplex (HP:0000943) | 3.24234714 |
| 9 | Mitochondrial inheritance (HP:0001427) | 3.23477544 |
| 10 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.08095267 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 3.00948332 |
| 12 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.97558891 |
| 13 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.97558891 |
| 14 | Progressive macrocephaly (HP:0004481) | 2.96178176 |
| 15 | Hepatic necrosis (HP:0002605) | 2.90831289 |
| 16 | Hepatocellular necrosis (HP:0001404) | 2.89836245 |
| 17 | Recurrent abscess formation (HP:0002722) | 2.89266767 |
| 18 | Purpura (HP:0000979) | 2.87556645 |
| 19 | Increased CSF lactate (HP:0002490) | 2.86264550 |
| 20 | Acute encephalopathy (HP:0006846) | 2.81122171 |
| 21 | Renal Fanconi syndrome (HP:0001994) | 2.79656347 |
| 22 | Recurrent bacterial skin infections (HP:0005406) | 2.77915908 |
| 23 | 3-Methylglutaconic aciduria (HP:0003535) | 2.76893599 |
| 24 | Loss of speech (HP:0002371) | 2.76777080 |
| 25 | Stomatitis (HP:0010280) | 2.75710707 |
| 26 | Hepatosplenomegaly (HP:0001433) | 2.61736207 |
| 27 | Progressive neurologic deterioration (HP:0002344) | 2.57425503 |
| 28 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.51890853 |
| 29 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.51890853 |
| 30 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.51890853 |
| 31 | Exertional dyspnea (HP:0002875) | 2.51755638 |
| 32 | Mucopolysacchariduria (HP:0008155) | 2.42346420 |
| 33 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.42346420 |
| 34 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.41438941 |
| 35 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.40247376 |
| 36 | Increased hepatocellular lipid droplets (HP:0006565) | 2.35447296 |
| 37 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.34761833 |
| 38 | Obstructive lung disease (HP:0006536) | 2.34185562 |
| 39 | Chronic obstructive pulmonary disease (HP:0006510) | 2.34185562 |
| 40 | Vertebral compression fractures (HP:0002953) | 2.33154693 |
| 41 | Increased cerebral lipofuscin (HP:0011813) | 2.29432306 |
| 42 | Generalized aminoaciduria (HP:0002909) | 2.26848371 |
| 43 | Respiratory failure (HP:0002878) | 2.26521569 |
| 44 | Increased IgM level (HP:0003496) | 2.24788136 |
| 45 | Eczematoid dermatitis (HP:0000976) | 2.24680675 |
| 46 | Pulmonary infiltrates (HP:0002113) | 2.20857905 |
| 47 | Increased serum ferritin (HP:0003281) | 2.16489647 |
| 48 | Prolonged neonatal jaundice (HP:0006579) | 2.15976174 |
| 49 | Albinism (HP:0001022) | 2.15934028 |
| 50 | Tongue fasciculations (HP:0001308) | 2.15680387 |
| 51 | Lipid accumulation in hepatocytes (HP:0006561) | 2.15569394 |
| 52 | Recurrent skin infections (HP:0001581) | 2.13940654 |
| 53 | Increased intramyocellular lipid droplets (HP:0012240) | 2.13104764 |
| 54 | Myositis (HP:0100614) | 2.12237776 |
| 55 | Gingival bleeding (HP:0000225) | 2.09391063 |
| 56 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.07039906 |
| 57 | Type I transferrin isoform profile (HP:0003642) | 2.06932869 |
| 58 | Aplastic anemia (HP:0001915) | 2.06808368 |
| 59 | Epistaxis (HP:0000421) | 2.06757054 |
| 60 | Nausea (HP:0002018) | 2.06547230 |
| 61 | Hypokinesia (HP:0002375) | 2.06253527 |
| 62 | Prolonged bleeding time (HP:0003010) | 2.04743300 |
| 63 | Cerebral edema (HP:0002181) | 2.04360627 |
| 64 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.03609752 |
| 65 | Muscle fibrillation (HP:0010546) | 2.01639957 |
| 66 | Congenital, generalized hypertrichosis (HP:0004540) | 2.01111451 |
| 67 | Abnormality of iron homeostasis (HP:0011031) | 1.99950341 |
| 68 | Pulmonary fibrosis (HP:0002206) | 1.97035393 |
| 69 | Orchitis (HP:0100796) | 1.95761973 |
| 70 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.93299091 |
| 71 | Vascular calcification (HP:0004934) | 1.92199311 |
| 72 | Increased muscle lipid content (HP:0009058) | 1.90980355 |
| 73 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.90631681 |
| 74 | Recurrent cutaneous fungal infections (HP:0011370) | 1.90631681 |
| 75 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.89892726 |
| 76 | Hemoptysis (HP:0002105) | 1.89303024 |
| 77 | Cardiovascular calcification (HP:0011915) | 1.87102065 |
| 78 | Lactic acidosis (HP:0003128) | 1.87044660 |
| 79 | Rough bone trabeculation (HP:0100670) | 1.86082047 |
| 80 | Oral leukoplakia (HP:0002745) | 1.85679731 |
| 81 | Hypergammaglobulinemia (HP:0010702) | 1.85071797 |
| 82 | Increased CSF protein (HP:0002922) | 1.84611299 |
| 83 | Abnormality of renal resorption (HP:0011038) | 1.82538188 |
| 84 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.81159373 |
| 85 | Mucosal telangiectasiae (HP:0100579) | 1.80555376 |
| 86 | Bone cyst (HP:0012062) | 1.79666271 |
| 87 | Recurrent fungal infections (HP:0002841) | 1.78987640 |
| 88 | Pustule (HP:0200039) | 1.78944347 |
| 89 | Urticaria (HP:0001025) | 1.78801397 |
| 90 | Axonal loss (HP:0003447) | 1.78136721 |
| 91 | Nuclear cataract (HP:0100018) | 1.77637024 |
| 92 | Retrobulbar optic neuritis (HP:0100654) | 1.77202451 |
| 93 | Optic neuritis (HP:0100653) | 1.77202451 |
| 94 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.74757346 |
| 95 | Vasculitis (HP:0002633) | 1.74056585 |
| 96 | Anorexia (HP:0002039) | 1.72194727 |
| 97 | Basal ganglia calcification (HP:0002135) | 1.72073611 |
| 98 | Polyneuropathy (HP:0001271) | 1.70302097 |
| 99 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.69612323 |
| 100 | Abnormal glycosylation (HP:0012345) | 1.69169400 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST4 | 4.02963251 |
| 2 | MAP3K12 | 3.97550047 |
| 3 | MYLK | 3.41021950 |
| 4 | NME2 | 2.81568670 |
| 5 | TESK1 | 2.70770431 |
| 6 | STK16 | 2.37199151 |
| 7 | VRK2 | 2.24359198 |
| 8 | LIMK1 | 2.14282864 |
| 9 | TXK | 2.11651701 |
| 10 | BMPR2 | 1.94542692 |
| 11 | TYK2 | 1.90688717 |
| 12 | MAP3K3 | 1.89326092 |
| 13 | IRAK3 | 1.85229964 |
| 14 | TESK2 | 1.81693396 |
| 15 | PIM2 | 1.76326675 |
| 16 | RIPK4 | 1.73632355 |
| 17 | PAK4 | 1.70801986 |
| 18 | GRK7 | 1.67593354 |
| 19 | BLK | 1.62990120 |
| 20 | EIF2AK1 | 1.62956565 |
| 21 | ABL2 | 1.61426141 |
| 22 | ILK | 1.60631649 |
| 23 | TBK1 | 1.59022703 |
| 24 | TGFBR2 | 1.58281559 |
| 25 | IKBKB | 1.51937195 |
| 26 | MAPKAPK3 | 1.44337517 |
| 27 | PDK2 | 1.32310541 |
| 28 | ZAP70 | 1.31998951 |
| 29 | SCYL2 | 1.30659705 |
| 30 | CSK | 1.24343221 |
| 31 | KDR | 1.19453853 |
| 32 | MAP4K1 | 1.19262352 |
| 33 | KIT | 1.18221841 |
| 34 | ERN1 | 1.17868917 |
| 35 | ADRBK2 | 1.17365030 |
| 36 | BCKDK | 1.17361060 |
| 37 | BMPR1B | 1.13604362 |
| 38 | EIF2AK3 | 1.11716099 |
| 39 | IKBKE | 1.09252137 |
| 40 | CSF1R | 1.07683067 |
| 41 | ARAF | 1.04104628 |
| 42 | JAK3 | 1.02821598 |
| 43 | DAPK3 | 1.01439055 |
| 44 | TEC | 0.99423234 |
| 45 | TAOK3 | 0.98980535 |
| 46 | GRK1 | 0.96360120 |
| 47 | IRAK4 | 0.94561628 |
| 48 | MAP4K2 | 0.91402888 |
| 49 | GRK6 | 0.89010354 |
| 50 | MAP3K14 | 0.88290011 |
| 51 | TRPM7 | 0.88168708 |
| 52 | LYN | 0.87821334 |
| 53 | SYK | 0.85700099 |
| 54 | TAOK2 | 0.82340743 |
| 55 | FRK | 0.81921771 |
| 56 | PTK2B | 0.80148368 |
| 57 | FES | 0.79272917 |
| 58 | TLK1 | 0.79047656 |
| 59 | STK10 | 0.77627878 |
| 60 | JAK1 | 0.76874388 |
| 61 | MAP2K3 | 0.76673283 |
| 62 | DAPK1 | 0.76632260 |
| 63 | PIK3CG | 0.74535247 |
| 64 | PBK | 0.73473939 |
| 65 | CDK8 | 0.68762251 |
| 66 | LRRK2 | 0.68563050 |
| 67 | MAP3K11 | 0.66124262 |
| 68 | MATK | 0.64954472 |
| 69 | FGR | 0.63088817 |
| 70 | DDR2 | 0.62856054 |
| 71 | STK24 | 0.62251587 |
| 72 | MST1R | 0.62221261 |
| 73 | ACVR1B | 0.61491693 |
| 74 | EPHA2 | 0.60720986 |
| 75 | BTK | 0.60509453 |
| 76 | FER | 0.60113428 |
| 77 | LCK | 0.58402966 |
| 78 | ITK | 0.57361297 |
| 79 | PRKG2 | 0.57160078 |
| 80 | NUAK1 | 0.56692609 |
| 81 | ADRBK1 | 0.55917797 |
| 82 | PAK1 | 0.55440601 |
| 83 | LMTK2 | 0.54521989 |
| 84 | GRK5 | 0.54005384 |
| 85 | HCK | 0.53443801 |
| 86 | VRK1 | 0.53144132 |
| 87 | MOS | 0.51837471 |
| 88 | BMX | 0.49615026 |
| 89 | PRKCD | 0.47743154 |
| 90 | ABL1 | 0.47477204 |
| 91 | TNK2 | 0.47339276 |
| 92 | TGFBR1 | 0.45859145 |
| 93 | ERBB3 | 0.44571450 |
| 94 | MUSK | 0.43496686 |
| 95 | ROCK1 | 0.43097471 |
| 96 | PRKCI | 0.42586285 |
| 97 | MAPKAPK2 | 0.42443074 |
| 98 | EPHB1 | 0.40459577 |
| 99 | NEK9 | 0.39595045 |
| 100 | CAMKK2 | 0.38460720 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.96815510 |
| 2 | * Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.27546358 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.73900558 |
| 4 | Asthma_Homo sapiens_hsa05310 | 2.71899139 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.67228033 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.48409029 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 2.41192022 |
| 8 | Protein export_Homo sapiens_hsa03060 | 2.39177949 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 2.39122346 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.36713302 |
| 11 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.32070218 |
| 12 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.24711363 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.23634672 |
| 14 | Lysosome_Homo sapiens_hsa04142 | 2.19486039 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.06296101 |
| 16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.06128617 |
| 17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.85535633 |
| 18 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.85219007 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.77961782 |
| 20 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.73608188 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.71961536 |
| 22 | Alzheimers disease_Homo sapiens_hsa05010 | 1.65278918 |
| 23 | Ribosome_Homo sapiens_hsa03010 | 1.61980346 |
| 24 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.56922892 |
| 25 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.53920120 |
| 26 | * Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.53224851 |
| 27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.46648914 |
| 28 | Huntingtons disease_Homo sapiens_hsa05016 | 1.45026888 |
| 29 | Leishmaniasis_Homo sapiens_hsa05140 | 1.43065882 |
| 30 | * Phagosome_Homo sapiens_hsa04145 | 1.41012708 |
| 31 | Viral myocarditis_Homo sapiens_hsa05416 | 1.33694096 |
| 32 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.32392911 |
| 33 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.25818875 |
| 34 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.19911817 |
| 35 | Tuberculosis_Homo sapiens_hsa05152 | 1.15506316 |
| 36 | Malaria_Homo sapiens_hsa05144 | 1.08394840 |
| 37 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.05431616 |
| 38 | Mineral absorption_Homo sapiens_hsa04978 | 1.05001056 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 1.04503352 |
| 40 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.03402733 |
| 41 | RNA polymerase_Homo sapiens_hsa03020 | 1.02124162 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.01838920 |
| 43 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.98994851 |
| 44 | * Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.98405120 |
| 45 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.97415618 |
| 46 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.96892105 |
| 47 | Pertussis_Homo sapiens_hsa05133 | 0.95857159 |
| 48 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.95737605 |
| 49 | Shigellosis_Homo sapiens_hsa05131 | 0.92309958 |
| 50 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.90464041 |
| 51 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.84610276 |
| 52 | Galactose metabolism_Homo sapiens_hsa00052 | 0.84526136 |
| 53 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.83609413 |
| 54 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.80803085 |
| 55 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.80615717 |
| 56 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.79262062 |
| 57 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.78725303 |
| 58 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.77321917 |
| 59 | Peroxisome_Homo sapiens_hsa04146 | 0.75637395 |
| 60 | Salmonella infection_Homo sapiens_hsa05132 | 0.75030840 |
| 61 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.73018266 |
| 62 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.72521726 |
| 63 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.72125280 |
| 64 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.69751382 |
| 65 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.67629424 |
| 66 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.67410832 |
| 67 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.64858896 |
| 68 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.63260058 |
| 69 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.61829674 |
| 70 | Measles_Homo sapiens_hsa05162 | 0.61313810 |
| 71 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61079466 |
| 72 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.60190681 |
| 73 | Influenza A_Homo sapiens_hsa05164 | 0.59519683 |
| 74 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.58494494 |
| 75 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.57658046 |
| 76 | * Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53225704 |
| 77 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.52943314 |
| 78 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.50885336 |
| 79 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.48865880 |
| 80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.47403064 |
| 81 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.46764472 |
| 82 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.46105266 |
| 83 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.45175399 |
| 84 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42955829 |
| 85 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.41797153 |
| 86 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.41131881 |
| 87 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.38451141 |
| 88 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.38209677 |
| 89 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.37566565 |
| 90 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.36322867 |
| 91 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.36074256 |
| 92 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.35259787 |
| 93 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.35220373 |
| 94 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.34060274 |
| 95 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.33499109 |
| 96 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.32887289 |
| 97 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.32246620 |
| 98 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.31485234 |
| 99 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.29015184 |
| 100 | Platelet activation_Homo sapiens_hsa04611 | 0.28874941 |

